Harsukh Parmar
Harsukh joins Roche from Astra Zeneca where he was VP and global head of early clinical development in the respiratory and inflammation therapeutic area.
In his new position – based at the company’s Nutley, US, division – he will be take charge of TM’s role in delivering first-in-class compounds to the lifecycle investment point.
Of his new appointment, Jacques Banchereau, Nutley's chief scientific officer said: “He will provide valuable expertise and advice on target selection and the development of early stage compounds in our Inflammation pipeline."
vio� � i�Z P� enior VP for global drug product manufacturing.